Port Site Metastases after Minimally Invasive Gynaecologic Cancer Surgery Prevention is better than Cure

Abstract

The last three decades have witnessed laparoscopy being used in cancer surgeries. Initial reports date back to 1970s [1-3]. The use of laparoscopy has been established in oncologic surgeries with innumerable advantages [4] such as being safe, less invasive, preservation of oncologic and immunologic functions and shorter intervals to start of adjuvant treatment if needed [5]. However, minimally invasive onco-surgeries may have complications like vascular injuries, bowel injuries, genitourinary injuries and port-site metastases (PSMs) [6,7]. PSM is a strong risk factor for peritoneal dissemination [8]. PSMs are associated with poor outcome of patients and represent significant patient morbidity and end-of-life care issues. PSMs can significantly increase patient morbidity and are associated with poor outcome.